Pfizer’s New Drug Shows Potential to Prevent Metastatic Disease

Pfizer’s New Drug Shows Potential to Prevent Metastatic Disease

Pfizer, the largest research-based pharmaceutical company in the world, has developed a new drug dubbed PD 0332991. It is being claimed after a trial of the same that it has the potential to stop aggressive breast cancer in progress.

The team says that the occurrence of the same is prevented for more than two years i. e. for a median of 26.1 months. However, if femara is given alone, patients could prevent the development of an incurable form of the disease for only 7.5 months.

The findings had been recently presented at the San Antonio Breast Cancer Symposium, which had involved some 165 patients with metastatic disease. All of them were given PD 0332991 along with Novartis (NOVN) AG's Femara.

Metastatic disease is the one in which cancer tends to spread to all other body parts of the patients, the report finds in the meanwhile. The same needs to be addressed sooner as possible since thousands of women are living with devastating conditions and dying as well.

It was noted that the drug was effective as well as safe. However, a larger trial is now being urged so as to confirm the benefits. "There will be gaps in our knowledge of how to give it and when. We're trying to move forward with a thoughtful, methodical approach", sources quoted Rothenberg as avowing.


FrenchTribune Specials

Scientist call for stoponmoratorium on Human Genome Modification

Global scientists are calling for a stop on any endeavours to change thehuman hereditary code until much more research can been conducted on the subject.

Researchers said that a new invention called CRISPR can allow scientists to modify the human hereditary code but experts are warning to wait until more research is conducted. It is not...

Most Popular

New “flying doctors” scheme to be launched in Wales

The new "flying doctors" scheme, which is a leading...

Britain in Search for Its National Bird

It is known that America has the bald eagle as its...

FDA approves ATX-101 drug that helps avoid double chin

The U. S. Food and Drug Administration (FDA)has given...

Study shows energy drinks affect blood pressure levels

According to a new study, energy drinksmay affect the...

Poll

Can Greece Come out of Economic Problems: